In fact, they drive the highest revenue per product, and that helps us drive our competitive advantage in that we have the best lifetime value, the best unit economics, which allows us to give value ...
Capital raised -- $37 million in gross proceeds from two public offerings, immediately deployed to accelerate commercial ...
Regulated information US organisation right-sized to meet current market needstargeting break-even in US from 2016 ThromboGenics clinical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results